 | • レポートコード：MRC22NVL19257 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥549,000 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,098,000 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年の複合電解質注入液の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界の複合電解質注入液市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界の複合電解質注入液市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国の複合電解質注入液市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の複合電解質注入液市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の複合電解質注入液の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要な複合電解質注入液プレーヤーとして、Baxter、 B Braun、 Otsuka Pharmaceutical、 ICU Medical、 Fresenius Kabi、 Hospira、 Pentagon Labs、 VetOne、 Dechra Pharmaceuticals、 Jiangsu Hengrui Medicine、 Jilin Sichang Pharmaceutical、 Luoxin Pharmaceutical、 Tibet Weixinkang Pharmaceutical、 Huaren Pharmaceutical、 Tibet Duo Rui Pharmaceuticalなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとの複合電解質注入液市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 250ml/袋、500ml/袋、1000ml/袋 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 病院、診療所、薬局 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：複合電解質注入液の年間販売量2017-2028、地域別現状・将来分析 ・複合電解質注入液のタイプ別セグメント：250ml/袋、500ml/袋、1000ml/袋 ・複合電解質注入液のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・複合電解質注入液の用途別セグメント：病院、診療所、薬局 ・複合電解質注入液の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界の複合電解質注入液市場 ・企業別のグローバル複合電解質注入液市場データ：2020-2022年の年間販売量、市場シェア ・企業別の複合電解質注入液の年間売上：2020-2022年の売上、市場シェア ・企業別の複合電解質注入液販売価格 ・主要企業の複合電解質注入液生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 複合電解質注入液の地域別レビュー ・地域別の複合電解質注入液市場規模2017-2022：年間販売量、売上 ・主要国別の複合電解質注入液市場規模2017-2022：年間販売量、売上 ・南北アメリカの複合電解質注入液販売の成長 ・アジア太平洋の複合電解質注入液販売の成長 ・欧州の複合電解質注入液販売の成長 ・中東・アフリカの複合電解質注入液販売の成長 南北アメリカ市場 ・南北アメリカの国別の複合電解質注入液販売量、売上（2017-2022） ・南北アメリカの複合電解質注入液の種類別販売量 ・南北アメリカの複合電解質注入液の用途別販売量 ・米国の複合電解質注入液市場 ・カナダの複合電解質注入液市場 ・メキシコの複合電解質注入液市場 ・ブラジルの複合電解質注入液市場 アジア太平洋市場 ・アジア太平洋の国別の複合電解質注入液販売量、売上（2017-2022） ・アジア太平洋の複合電解質注入液の種類別販売量 ・アジア太平洋の複合電解質注入液の用途別販売量 ・中国市場の複合電解質注入液市場 ・日本市場の複合電解質注入液市場 ・韓国市場の複合電解質注入液市場 ・東南アジアの複合電解質注入液市場 ・インドの複合電解質注入液市場 ・オーストラリアの複合電解質注入液市場 ・台湾の複合電解質注入液市場 欧州市場 ・欧州の国別の複合電解質注入液販売量、売上（2017-2022） ・欧州の複合電解質注入液の種類別販売量 ・欧州の複合電解質注入液の用途別販売量 ・ドイツの複合電解質注入液市場 ・フランスの複合電解質注入液市場 ・イギリスの複合電解質注入液市場 ・イタリアの複合電解質注入液市場 ・ロシアの複合電解質注入液市場 中東・アフリカ市場 ・中東・アフリカの国別の複合電解質注入液販売量、売上（2017-2022） ・中東・アフリカの複合電解質注入液の種類別販売量 ・中東・アフリカの複合電解質注入液の用途別販売量 ・エジプトの複合電解質注入液市場 ・南アフリカの複合電解質注入液市場 ・イスラエルの複合電解質注入液市場 ・トルコの複合電解質注入液市場 ・GCC諸国の複合電解質注入液市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・複合電解質注入液の製造コスト構造分析 ・複合電解質注入液の製造プロセス分析 ・複合電解質注入液の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・複合電解質注入液の主要なグローバル販売業者 ・複合電解質注入液の主要なグローバル顧客 地域別の複合電解質注入液市場予測レビュー ・地域別の複合電解質注入液市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・複合電解質注入液のタイプ別市場規模予測 ・複合電解質注入液の用途別市場規模予測 主要企業分析 Baxter、 B Braun、 Otsuka Pharmaceutical、 ICU Medical、 Fresenius Kabi、 Hospira、 Pentagon Labs、 VetOne、 Dechra Pharmaceuticals、 Jiangsu Hengrui Medicine、 Jilin Sichang Pharmaceutical、 Luoxin Pharmaceutical、 Tibet Weixinkang Pharmaceutical、 Huaren Pharmaceutical、 Tibet Duo Rui Pharmaceutical ・企業情報 ・複合電解質注入液製品 ・複合電解質注入液販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Multiple Electrolytes Injection will have significant change from previous year. According to our (LP Information) latest study, the global Multiple Electrolytes Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Multiple Electrolytes Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Multiple Electrolytes Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Multiple Electrolytes Injection market, reaching US$ million by the year 2028. As for the Europe Multiple Electrolytes Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Multiple Electrolytes Injection players cover Baxter, B Braun, Otsuka Pharmaceutical, and ICU Medical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Multiple Electrolytes Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
250ml/Bag
500ml/Bag
1000ml/Bag
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
B Braun
Otsuka Pharmaceutical
ICU Medical
Fresenius Kabi
Hospira
Pentagon Labs
VetOne
Dechra Pharmaceuticals
Jiangsu Hengrui Medicine
Jilin Sichang Pharmaceutical
Luoxin Pharmaceutical
Tibet Weixinkang Pharmaceutical
Huaren Pharmaceutical
Tibet Duo Rui Pharmaceutical
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Multiple Electrolytes Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Multiple Electrolytes Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Multiple Electrolytes Injection by Country/Region, 2017, 2022 & 2028
2.2 Multiple Electrolytes Injection Segment by Type
2.2.1 250ml/Bag
2.2.2 500ml/Bag
2.2.3 1000ml/Bag
2.3 Multiple Electrolytes Injection Sales by Type
2.3.1 Global Multiple Electrolytes Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Multiple Electrolytes Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Multiple Electrolytes Injection Sale Price by Type (2017-2022)
2.4 Multiple Electrolytes Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Multiple Electrolytes Injection Sales by Application
2.5.1 Global Multiple Electrolytes Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Multiple Electrolytes Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Multiple Electrolytes Injection Sale Price by Application (2017-2022)
3 Global Multiple Electrolytes Injection by Company
3.1 Global Multiple Electrolytes Injection Breakdown Data by Company
3.1.1 Global Multiple Electrolytes Injection Annual Sales by Company (2020-2022)
3.1.2 Global Multiple Electrolytes Injection Sales Market Share by Company (2020-2022)
3.2 Global Multiple Electrolytes Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Multiple Electrolytes Injection Revenue by Company (2020-2022)
3.2.2 Global Multiple Electrolytes Injection Revenue Market Share by Company (2020-2022)
3.3 Global Multiple Electrolytes Injection Sale Price by Company
3.4 Key Manufacturers Multiple Electrolytes Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Multiple Electrolytes Injection Product Location Distribution
3.4.2 Players Multiple Electrolytes Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Multiple Electrolytes Injection by Geographic Region
4.1 World Historic Multiple Electrolytes Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Multiple Electrolytes Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Multiple Electrolytes Injection Annual Revenue by Geographic Region
4.2 World Historic Multiple Electrolytes Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Multiple Electrolytes Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Multiple Electrolytes Injection Annual Revenue by Country/Region
4.3 Americas Multiple Electrolytes Injection Sales Growth
4.4 APAC Multiple Electrolytes Injection Sales Growth
4.5 Europe Multiple Electrolytes Injection Sales Growth
4.6 Middle East & Africa Multiple Electrolytes Injection Sales Growth
5 Americas
5.1 Americas Multiple Electrolytes Injection Sales by Country
5.1.1 Americas Multiple Electrolytes Injection Sales by Country (2017-2022)
5.1.2 Americas Multiple Electrolytes Injection Revenue by Country (2017-2022)
5.2 Americas Multiple Electrolytes Injection Sales by Type
5.3 Americas Multiple Electrolytes Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multiple Electrolytes Injection Sales by Region
6.1.1 APAC Multiple Electrolytes Injection Sales by Region (2017-2022)
6.1.2 APAC Multiple Electrolytes Injection Revenue by Region (2017-2022)
6.2 APAC Multiple Electrolytes Injection Sales by Type
6.3 APAC Multiple Electrolytes Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Multiple Electrolytes Injection by Country
7.1.1 Europe Multiple Electrolytes Injection Sales by Country (2017-2022)
7.1.2 Europe Multiple Electrolytes Injection Revenue by Country (2017-2022)
7.2 Europe Multiple Electrolytes Injection Sales by Type
7.3 Europe Multiple Electrolytes Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Multiple Electrolytes Injection by Country
8.1.1 Middle East & Africa Multiple Electrolytes Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Multiple Electrolytes Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Multiple Electrolytes Injection Sales by Type
8.3 Middle East & Africa Multiple Electrolytes Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Multiple Electrolytes Injection
10.3 Manufacturing Process Analysis of Multiple Electrolytes Injection
10.4 Industry Chain Structure of Multiple Electrolytes Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Multiple Electrolytes Injection Distributors
11.3 Multiple Electrolytes Injection Customer
12 World Forecast Review for Multiple Electrolytes Injection by Geographic Region
12.1 Global Multiple Electrolytes Injection Market Size Forecast by Region
12.1.1 Global Multiple Electrolytes Injection Forecast by Region (2023-2028)
12.1.2 Global Multiple Electrolytes Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Multiple Electrolytes Injection Forecast by Type
12.7 Global Multiple Electrolytes Injection Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Multiple Electrolytes Injection Product Offered
13.1.3 Baxter Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 B Braun
13.2.1 B Braun Company Information
13.2.2 B Braun Multiple Electrolytes Injection Product Offered
13.2.3 B Braun Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 B Braun Main Business Overview
13.2.5 B Braun Latest Developments
13.3 Otsuka Pharmaceutical
13.3.1 Otsuka Pharmaceutical Company Information
13.3.2 Otsuka Pharmaceutical Multiple Electrolytes Injection Product Offered
13.3.3 Otsuka Pharmaceutical Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Otsuka Pharmaceutical Main Business Overview
13.3.5 Otsuka Pharmaceutical Latest Developments
13.4 ICU Medical
13.4.1 ICU Medical Company Information
13.4.2 ICU Medical Multiple Electrolytes Injection Product Offered
13.4.3 ICU Medical Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 ICU Medical Main Business Overview
13.4.5 ICU Medical Latest Developments
13.5 Fresenius Kabi
13.5.1 Fresenius Kabi Company Information
13.5.2 Fresenius Kabi Multiple Electrolytes Injection Product Offered
13.5.3 Fresenius Kabi Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Fresenius Kabi Main Business Overview
13.5.5 Fresenius Kabi Latest Developments
13.6 Hospira
13.6.1 Hospira Company Information
13.6.2 Hospira Multiple Electrolytes Injection Product Offered
13.6.3 Hospira Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hospira Main Business Overview
13.6.5 Hospira Latest Developments
13.7 Pentagon Labs
13.7.1 Pentagon Labs Company Information
13.7.2 Pentagon Labs Multiple Electrolytes Injection Product Offered
13.7.3 Pentagon Labs Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pentagon Labs Main Business Overview
13.7.5 Pentagon Labs Latest Developments
13.8 VetOne
13.8.1 VetOne Company Information
13.8.2 VetOne Multiple Electrolytes Injection Product Offered
13.8.3 VetOne Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 VetOne Main Business Overview
13.8.5 VetOne Latest Developments
13.9 Dechra Pharmaceuticals
13.9.1 Dechra Pharmaceuticals Company Information
13.9.2 Dechra Pharmaceuticals Multiple Electrolytes Injection Product Offered
13.9.3 Dechra Pharmaceuticals Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Dechra Pharmaceuticals Main Business Overview
13.9.5 Dechra Pharmaceuticals Latest Developments
13.10 Jiangsu Hengrui Medicine
13.10.1 Jiangsu Hengrui Medicine Company Information
13.10.2 Jiangsu Hengrui Medicine Multiple Electrolytes Injection Product Offered
13.10.3 Jiangsu Hengrui Medicine Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jiangsu Hengrui Medicine Main Business Overview
13.10.5 Jiangsu Hengrui Medicine Latest Developments
13.11 Jilin Sichang Pharmaceutical
13.11.1 Jilin Sichang Pharmaceutical Company Information
13.11.2 Jilin Sichang Pharmaceutical Multiple Electrolytes Injection Product Offered
13.11.3 Jilin Sichang Pharmaceutical Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jilin Sichang Pharmaceutical Main Business Overview
13.11.5 Jilin Sichang Pharmaceutical Latest Developments
13.12 Luoxin Pharmaceutical
13.12.1 Luoxin Pharmaceutical Company Information
13.12.2 Luoxin Pharmaceutical Multiple Electrolytes Injection Product Offered
13.12.3 Luoxin Pharmaceutical Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Luoxin Pharmaceutical Main Business Overview
13.12.5 Luoxin Pharmaceutical Latest Developments
13.13 Tibet Weixinkang Pharmaceutical
13.13.1 Tibet Weixinkang Pharmaceutical Company Information
13.13.2 Tibet Weixinkang Pharmaceutical Multiple Electrolytes Injection Product Offered
13.13.3 Tibet Weixinkang Pharmaceutical Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Tibet Weixinkang Pharmaceutical Main Business Overview
13.13.5 Tibet Weixinkang Pharmaceutical Latest Developments
13.14 Huaren Pharmaceutical
13.14.1 Huaren Pharmaceutical Company Information
13.14.2 Huaren Pharmaceutical Multiple Electrolytes Injection Product Offered
13.14.3 Huaren Pharmaceutical Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Huaren Pharmaceutical Main Business Overview
13.14.5 Huaren Pharmaceutical Latest Developments
13.15 Tibet Duo Rui Pharmaceutical
13.15.1 Tibet Duo Rui Pharmaceutical Company Information
13.15.2 Tibet Duo Rui Pharmaceutical Multiple Electrolytes Injection Product Offered
13.15.3 Tibet Duo Rui Pharmaceutical Multiple Electrolytes Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Tibet Duo Rui Pharmaceutical Main Business Overview
13.15.5 Tibet Duo Rui Pharmaceutical Latest Developments
14 Research Findings and Conclusion